Literature DB >> 8218695

Clinical pharmacokinetics of continuous intravenous administration of penicillins.

L G Visser1, P Arnouts, R van Furth, H Mattie, P J van den Broek.   

Abstract

Theoretically, continuous intravenous administration of beta-lactam antibiotics has advantages over intermittent administration because of the close relationship between efficacy and the time the plasma concentration remains above the minimal inhibitory concentration that has been found in vitro. The aim of the present study was to establish the pharmacokinetic parameters of benzylpenicillin and cloxacillin administration in patients receiving high-dose benzylpenicillin or cloxacillin therapy by continuous infusion. A major part of the interindividual variation in the plasma concentrations at steady-state was attributable to variation in renal function, as estimated by the creatinine clearance. On the basis of these results, a nomogram was constructed that can be used to determine on an individualized basis the total daily dose of benzylpenicillin or cloxacillin necessary for each patient to obtain therapeutic plasma concentrations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8218695     DOI: 10.1093/clinids/17.3.491

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  8 in total

1.  Simultaneous determination of 12 beta-lactam antibiotics in human plasma by high-performance liquid chromatography with UV detection: application to therapeutic drug monitoring.

Authors:  Marie-Clémence Verdier; Olivier Tribut; Pierre Tattevin; Yves Le Tulzo; Christian Michelet; Danièle Bentué-Ferrer
Journal:  Antimicrob Agents Chemother       Date:  2011-07-25       Impact factor: 5.191

Review 2.  Management of antimicrobial use in the intensive care unit.

Authors:  F Alvarez-Lerma; M Palomar; S Grau
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  The renal clearance of cefuroxime and ceftazidime and the effect of probenecid on their tubular excretion.

Authors:  C A Verhagen; H Mattie; E Van Strijen
Journal:  Br J Clin Pharmacol       Date:  1994-02       Impact factor: 4.335

Review 4.  Continuous infusion of beta-lactam antibiotics.

Authors:  A P MacGowan; K E Bowker
Journal:  Clin Pharmacokinet       Date:  1998-11       Impact factor: 6.447

Review 5.  Antibiotic selection factors and description of a hospital-based outpatient antibiotic therapy program in the USA.

Authors:  W A Craig
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-07       Impact factor: 3.267

6.  Systematic overdosing of oxa- and cloxacillin in severe infections treated in ICU: risk factors and side effects.

Authors:  Mathilde Neuville; Najoua El-Helali; Eric Magalhaes; Aguila Radjou; Roland Smonig; Jean-François Soubirou; Guillaume Voiriot; Alban Le Monnier; Stéphane Ruckly; Lila Bouadma; Romain Sonneville; Jean-François Timsit; Bruno Mourvillier
Journal:  Ann Intensive Care       Date:  2017-03-22       Impact factor: 6.925

7.  Population pharmacokinetics and dosing optimization of cefathiamidine in children with hematologic infection.

Authors:  Li-Juan Zhi; Li Wang; Zhong-Ren Shi; Wei Zhao; Xing-Kai Chen; Xiao-Ying Zhai; Li Wen; Lei Dong; Evelyne Jacqz-Aigrain
Journal:  Drug Des Devel Ther       Date:  2018-04-17       Impact factor: 4.162

8.  Developmental Population Pharmacokinetics and Dosing Optimization of Cefepime in Neonates and Young Infants.

Authors:  Yang Zhao; Bu-Fan Yao; Chen Kou; Hai-Yan Xu; Bo-Hao Tang; Yue-E Wu; Guo-Xiang Hao; Xin-Ping Zhang; Wei Zhao
Journal:  Front Pharmacol       Date:  2020-02-04       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.